Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05923749 · ClinicalTrials.gov registry record · NA
A RCT Evaluating the Clinical Benefit of a Silver Dressing in the Treatment of Venous Leg Ulcers
A NA study, sponsored by Coloplast A/S.
- Completed
- Registry status
- NA
- Development phase
- 180
- Enrollment target
NCT05923749 is a NA study that has completed, run by Coloplast A/S. The registered enrollment target is 180 participants.
The verdict
NCT05923749, a NA study, has completed, sponsored by Coloplast A/S.
- COMPLETED
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
Study Summary
Approximately 178 patients with a venous leg ulcer will be included in the investigation evaluating wound healing. All subjects are randomized to one of two treatment arms with an intervention period of 4 weeks followed by a 8 week standard of care period.
Interventions
- DEVICE Biatain Ag
- DEVICE Cutimed Siltec Sorbact
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2023-06-29 |
| Est. Completion | 2025-01-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05923749
The ClinicalTrials.gov registry entry for NCT05923749 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Coloplast A/S, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Biatain Ag is the first listed.
NCT05923749 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05923749 about?
NCT05923749 is a clinical study titled "A RCT Evaluating the Clinical Benefit of a Silver Dressing in the Treatment of Venous Leg Ulcers". Approximately 178 patients with a venous leg ulcer will be included in the investigation evaluating wound healing. All subjects are randomized to one of two treatment arms with an intervention period of 4 weeks followed by a 8 week standard of care period.
What is the current status of trial NCT05923749?
This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2023-06-29. Estimated completion is 2025-01-29.
What interventions are being tested in trial NCT05923749?
The interventions under investigation include: Biatain Ag (DEVICE), Cutimed Siltec Sorbact (DEVICE).
Who is sponsoring clinical trial NCT05923749?
This trial is sponsored by Coloplast A/S, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.